Lazard Asset Management’s Nu Skin NUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $729K | Sell |
137,995
-192,652
| -58% | -$1.23M | ﹤0.01% | 1314 |
|
|
2026
Q1 | $2.41M | Buy |
330,647
+154,814
| +88% | +$1.4M | ﹤0.01% | 811 |
|
|
2025
Q4 | $1.69M | Buy |
175,833
+37,521
| +27% | +$388K | ﹤0.01% | 942 |
|
|
2025
Q3 | $1.69M | Buy |
138,312
+128,174
| +1,264% | +$1.35M | ﹤0.01% | 925 |
|
|
2025
Q2 | $81K | Hold |
10,138
| – | – | ﹤0.01% | 1910 |
|
|
2025
Q1 | $73K | Sell |
10,138
-1,533
| -13% | -$11.1K | ﹤0.01% | 1903 |
|
|
2024
Q4 | $80K | Buy |
+11,671
| New | +$80.3K | ﹤0.01% | 1871 |
|
|
2024
Q3 | – | Sell |
-8,312
| Closed | -$87K | – | 2393 |
|
|
2024
Q2 | $87K | Buy |
8,312
+3,725
| +81% | +$47.2K | ﹤0.01% | 1789 |
|
|
2024
Q1 | $63K | Buy |
4,587
+2,206
| +93% | +$34.4K | ﹤0.01% | 1674 |
|
|
2023
Q4 | $46K | Buy |
2,381
+1,474
| +163% | +$27.2K | ﹤0.01% | 1906 |
|
|
2023
Q3 | $19K | Hold |
907
| – | – | ﹤0.01% | 2107 |
|
|
2023
Q2 | $30K | Buy |
+907
| New | +$33.4K | ﹤0.01% | 2000 |
|
|
2021
Q4 | – | Sell |
-384
| Closed | -$15K | – | 2408 |
|
|
2021
Q3 | $15K | Sell |
384
-1,036
| -73% | -$52.4K | ﹤0.01% | 2051 |
|
|
2021
Q2 | $80K | Buy |
1,420
+6
| +0.4% | +$342 | ﹤0.01% | 1417 |
|
|
2021
Q1 | $74K | Buy |
1,414
+126
| +10% | +$6.86K | ﹤0.01% | 1282 |
|
|
2020
Q4 | $70K | Buy |
1,288
+354
| +38% | +$18.6K | ﹤0.01% | 1281 |
|
|
2020
Q3 | $46K | Buy |
+934
| New | +$44.3K | ﹤0.01% | 1210 |
|
|
2020
Q2 | – | Sell |
-1,096
| Closed | -$23K | – | 1733 |
|
|
2020
Q1 | $23K | Buy |
+1,096
| New | +$33K | ﹤0.01% | 1407 |
|
|
2019
Q3 | – | Sell |
-76,008
| Closed | -$3.75M | – | 1536 |
|
|
2019
Q2 | $3.75M | Buy |
+76,008
| New | +$3.87M | 0.01% | 652 |
|
|
2019
Q1 | – | Sell |
-16,387
| Closed | -$1M | – | 1185 |
|
|
2018
Q4 | $1M | Sell |
16,387
-200
| -1% | -$13.5K | ﹤0.01% | 725 |
|
|
2018
Q3 | $1.37M | Sell |
16,587
-360
| -2% | -$28.6K | ﹤0.01% | 700 |
|
|
2018
Q2 | $1.32M | Buy |
16,947
+16,379
| +2,884% | +$1.27M | ﹤0.01% | 706 |
|
|
2018
Q1 | $41K | Buy |
+568
| New | +$40.3K | ﹤0.01% | 929 |
|
|
2014
Q1 | – | Sell |
-3,422
| Closed | -$472K | – | 1052 |
|
|
2013
Q4 | $472K | Buy |
3,422
+3,373
| +6,884% | +$397K | ﹤0.01% | 758 |
|
|
2013
Q3 | $4K | Hold |
49
| – | – | ﹤0.01% | 928 |
|
|
2013
Q2 | $2K | Buy |
+49
| New | +$2.72K | ﹤0.01% | 1010 |
|
Other funds holding NUS
CAS
PGCM
Lazard Asset Management's NUS Position: Q2 2026 in Review
Lazard Asset Management reduced its Nu Skin (NUS) stake by 58% in Q2 2026, selling an estimated $1.23M and leaving 137,995 shares worth $729K. The position accounts for ﹤0.01% of the portfolio, ranked #1314.
Lazard Asset Management first reported a position in NUS in Q2 2013 and has held it in 26 quarters since. The position peaked at $3.75M in Q2 2019. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.
- Lazard Asset Management held 137,995 shares of Nu Skin worth $729K as of Q2 2026.
- Lazard Asset Management sold 192,652 Nu Skin shares in Q2 2026, an estimated $1.23M.
- Nu Skin made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1314 holding.
- Lazard Asset Management first reported a position in Nu Skin in Q2 2013 and has held it in 26 quarters since.
- Lazard Asset Management's Nu Skin position peaked at $3.75M in Q2 2019.
- 162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.
Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.